Spyre Therapeutics Inc <SYRE.O>: BTIG cuts target price to $121 from $132
SYRE•Related News
BOJ chief Ueda to skip Jackson Hole, shifts market focus to G20
TLT•
Dollar moves in a narrow range ahead of inflation data, Jackson Hole
SPY•
TABLE-North Sea gas maintenance schedule: Adds Karsto outage
XLE•
Advasa Holdings, Inc. Completed A Direct Listing On Nasdaq Under The Ticker Symbol "ADBT"
ADBT•
Copper firms on worries over dwindling LME inventories
COPX•